Adjuvant composition, and vaccine composition and drug kit each containing the same
US11517620B2 · kind B2 · utility
0Cited by
3References
4Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Mar 28, 2018 |
| Grant date | Dec 6, 2022 |
| Priority date | — |
| Expiry date | Jun 26, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/76
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A combination of drugs having a higher antitumor effect is provided. There is provided an adjuvant composition containing a pH sensitive carrier and a natural immunity-activating substance, the adjuvant composition being used to be administered in combination with an immune checkpoint inhibitor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.